孔凡霞 1陈晓乐 2杜秋香 2李楠 1罗清霞 1段红萍 1顾海霞3
作者信息
- 1. 邯郸市第三医院药剂科 河北 邯郸 056001
- 2. 邯郸市第三医院检验科 河北 邯郸 056001
- 3. 邯郸市第三医院眼科 河北 邯郸 056001
- 折叠
摘要
Abstract
Objective: To investigate the recombinant human thrombopoietin, corticosteroids, cyclosporin A combined therapy to reduce purpura 75 cases of immune thrombocytopenic. Methods: From 2011 March to 2014 January in our hospital were treated with immune thrombocytopenic purpura patients a total of 75 cases, were given the treatment of thrombopoietin, corticosteroids, cyclosporin A recombinant human, compared before and after treatment (platelet), PLT (WBC), WBC (hemoglobin) Hb changes and the total curative effect of therapy. Results:Before treatment, PLT, WBC, Hb were (14.41+2.11)×109/L, (8.92+1.01)×109/L, (119.32+9.8)g/L, respectively after treatment for (118.92+14.50)×109/L, (9.01+1.05)×109/L, (120.14+6.84) g/L, the number of platelet therapy significantly higher than before treatment (t=61.769, P=0.000), WBC, Hb before and after treatment showed no statistical significance (t=0.535, P=0.593;t=0.594, P=0.0553). The total curative effect in the treatment of treatment was 89.3%(67/75), the rate of adverse reaction was 4%. Conclusion:The combined application of recombinant human thrombopoietin, corticosteroids, cyclosporin A in the treatment of ITP curative effect is good, significantly improve the platelet count, worthy of promotion.关键词
重组人血小板生成素/糖皮质激素/环孢素A/免疫性血小板减少性紫癜Key words
Recombinant human thrombopoietin/Glucocorticoid/Cyclosporine A/Immune thrombocytopenic purpura分类
医药卫生
